Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boswell

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1980
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulationH S Boswell, A Ahmed, I Scher, et al.
The Journal of Experimental Medicine|January 1, 1994
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathwayT Tauchi, H S Boswell, D Leibowitz, et al.
The Journal of Experimental Medicine|November 1, 1980
Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defectH S Boswell, M I Nerenberg, I Scher, et al.
Leukemia|August 1, 1992
BCR/ABL confers growth factor independence upon a murine myeloid cell lineR A Mandanas, H S Boswell, L Lu, et al.
Leukemia Research|August 1, 1993
Mutant H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cellsJ Moore, S Boswell, R Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Role of accessory cells in B cell activation. IV. Ia+ accessory cells are required for the in vitro generation of thymic independent type 2 antibody responses to polysaccharide antigensP J Morrissey, H S Boswell, I Scher, et al.
Blood|November 1, 1989
Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferationH G Derigs, D Klingberg, G J Tricot, et al.
Cellular Signalling|January 1, 1991
Expression of val-12 mutant ras p21 in an IL-3-dependent murine myeloid cell line is associated with loss of serum-dependence and increases in membrane PIP2-specific phospholipase C activityM T Rizzo, H S Boswell, D English, et al.
Leukemia|February 1, 1987
A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical resultsL Elias, R Hoffman, S Boswell, et al.
Journal of the California Dental Association|September 1, 1990
1990 USC esthetic dentistry symposiumC Thanos, M H Friedman, J Sorensen, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1980
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulationH S Boswell, A Ahmed, I Scher, et al.
The Journal of Experimental Medicine|January 1, 1994
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathwayT Tauchi, H S Boswell, D Leibowitz, et al.
The Journal of Experimental Medicine|November 1, 1980
Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defectH S Boswell, M I Nerenberg, I Scher, et al.
Leukemia|August 1, 1992
BCR/ABL confers growth factor independence upon a murine myeloid cell lineR A Mandanas, H S Boswell, L Lu, et al.
Leukemia Research|August 1, 1993
Mutant H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cellsJ Moore, S Boswell, R Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Role of accessory cells in B cell activation. IV. Ia+ accessory cells are required for the in vitro generation of thymic independent type 2 antibody responses to polysaccharide antigensP J Morrissey, H S Boswell, I Scher, et al.
Blood|November 1, 1989
Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferationH G Derigs, D Klingberg, G J Tricot, et al.
Cellular Signalling|January 1, 1991
Expression of val-12 mutant ras p21 in an IL-3-dependent murine myeloid cell line is associated with loss of serum-dependence and increases in membrane PIP2-specific phospholipase C activityM T Rizzo, H S Boswell, D English, et al.
Leukemia|February 1, 1987
A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical resultsL Elias, R Hoffman, S Boswell, et al.
Journal of the California Dental Association|September 1, 1990
1990 USC esthetic dentistry symposiumC Thanos, M H Friedman, J Sorensen, et al.
Pageof 11